133 related articles for article (PubMed ID: 25453818)
1. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.
Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818
[TBL] [Abstract][Full Text] [Related]
2. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
[TBL] [Abstract][Full Text] [Related]
3. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity.
Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A
Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Rigo B; Bîcu E
Bioorg Med Chem Lett; 2013 Nov; 23(21):5887-92. PubMed ID: 24054122
[TBL] [Abstract][Full Text] [Related]
5. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
[TBL] [Abstract][Full Text] [Related]
6. Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase.
Dumitriu GM; Ghinet A; Bîcu E; Rigo B; Dubois J; Farce A; Belei D
Bioorg Med Chem Lett; 2014 Jul; 24(14):3180-5. PubMed ID: 24856060
[TBL] [Abstract][Full Text] [Related]
7. Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitors.
Homerin G; Nica AS; Farce A; Dubois J; Ghinet A
Bioorg Med Chem Lett; 2020 Jun; 30(11):127149. PubMed ID: 32247731
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
9. New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives.
Sonnet P; Dallemagne P; Guillon J; Enguehard C; Stiebing S; Tanguy J; Bureau R; Rault S; Auvray P; Moslemi S; Sourdaine P; Séralini GE
Bioorg Med Chem; 2000 May; 8(5):945-55. PubMed ID: 10882007
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Action of Indolizines as Biologically Active Moieties: A Molecular Dynamics Study.
Szefler B; Czelen P; Diudea MV
Curr Comput Aided Drug Des; 2017; 13(1):22-29. PubMed ID: 27719631
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
[TBL] [Abstract][Full Text] [Related]
12. Exploring isoxazoles and pyrrolidinones decorated with the 4,6-dimethoxy-1,3,5-triazine unit as human farnesyltransferase inhibitors.
Lucescu L; Ghinet A; Shova S; Magnez R; Thuru X; Farce A; Rigo B; Belei D; Dubois J; Bîcu E
Arch Pharm (Weinheim); 2019 May; 352(5):e1800227. PubMed ID: 30947375
[TBL] [Abstract][Full Text] [Related]
13. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
Xue Y; Tang J; Ma X; Li Q; Xie B; Hao Y; Jin H; Wang K; Zhang G; Zhang L; Zhang L
Eur J Med Chem; 2016 Jun; 115():94-108. PubMed ID: 26994846
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors.
Li X; Li L; Zhou Q; Zhang N; Zhang S; Zhao R; Liu D; Jing Y; Zhao L
Bioorg Med Chem Lett; 2014 Dec; 24(24):5612-5615. PubMed ID: 25466185
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Gautret P; Rigo B; Belei D; Bîcu E
Eur J Med Chem; 2013 Jan; 59():101-10. PubMed ID: 23207411
[TBL] [Abstract][Full Text] [Related]
17. Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.
Dumitriu GM; Bîcu E; Belei D; Rigo B; Dubois J; Farce A; Ghinet A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4447-52. PubMed ID: 26372651
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
[TBL] [Abstract][Full Text] [Related]
19. Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking.
Xie A; Odde S; Prasanna S; Doerksen RJ
J Comput Aided Mol Des; 2009 Jul; 23(7):431-48. PubMed ID: 19479325
[TBL] [Abstract][Full Text] [Related]
20. Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.
Huang W; Zuo T; Luo X; Jin H; Liu Z; Yang Z; Yu X; Zhang L; Zhang L
Chem Biol Drug Des; 2013 Jun; 81(6):730-41. PubMed ID: 23405965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
